Clemson professor receives award to study effect of mothers' obesity, diabetes on infants

October 27, 2009

CLEMSON -- The National Institutes of Health has awarded Clemson University professor Maria Mayorga and Medical University of South Carolina professor Kelly Hunt a $735,000 grant to study the effects of a mother's obesity and diabetes on infant health in certain ethnic groups.

Mayorga, an industrial engineer, and Hunt, an epidemiologist, will team up for three years to create a novel computer simulation model that will predict the impact of obesity and diabetes during pregnancy on African-American, non-Hispanic white and Hispanic populations.

The research will focus on whether prenatal risk factors, such as obesity and diabetes, affect an infant's chance for developing these conditions later in life. If this is the case, Mayorga said obesity and diabetes not only will continue to affect all populations, but ethnic groups that are already at risk for the diseases will continue to be disproportionately affected.

"Members of the two largest minority groups in the U.S., African-American and Hispanic women, are more likely to be obese and have diabetes during pregnancy than non-Hispanic white women," said Mayorga. "Their body fat is distributed differently, their diabetes is more severe and they have a higher risk of cardiovascular problems than non-Hispanic whites. These issues of racial-ethnic differences in the intrauterine environment have been explored by a small number of researchers and, if left as is, may continue to perpetuate themselves."
-end-
This material is based upon work supported by the NIH National Center on Minority Health and Health Disparities under Grant No. 1R01MD004251-01. Any opinions, findings and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Institutes of Health.

contact:
Maria Mayorga
(864) 656-6919
mayorga@clemson.edu

Clemson University

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.